Tapewire

Nasdaq · USD

LEGN

Legend Biotech Corp

Export transactions ↓
Tapewire entity
4033
SEC CIK
0001801198
Parsed reports
28

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 29, 2026 Filed Oct 2, 2026 00:04 UTC SaleOrdinary Shares 27,370 $9.46 $258,920.20
Disclosure

SEC source: 0001796536-26-000010 · form4-10012026_081003.xml · nonDerivative · entry 1

Sanders Corazon (Corsee) D. · CIK 0001796536 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,731

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · price: The price reported in Column 4 is a weighted average price. The prices sold ranged from $9.445 to $9.48 per ordinary share. The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 24, 2026 Filed Sep 28, 2026 20:10 UTC GrantOrdinary Shares 20,986 $0.00 $0.00
Disclosure

SEC source: 0001796536-26-000009 · form4-09282026_040901.xml · nonDerivative · entry 1

Sanders Corazon (Corsee) D. · CIK 0001796536 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,101

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · shares: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
September 24, 2026 Filed Sep 28, 2026 20:10 UTC GrantOrdinary Shares 28,330 $0.00 $0.00
Disclosure

SEC source: 0001974687-26-000006 · form4-09282026_040904.xml · nonDerivative · entry 1

Ji Darren Xiaohui · CIK 0001974687 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,103

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · shares: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
September 24, 2026 Filed Sep 28, 2026 20:10 UTC GrantOrdinary Shares 20,986 $0.00 $0.00
Disclosure

SEC source: 0002068365-26-000009 · form4-09282026_040906.xml · nonDerivative · entry 1

Casey Patrick John · CIK 0002068365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,590

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · shares: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
September 24, 2026 Filed Sep 28, 2026 20:10 UTC
Mao LiDirector
GrantOrdinary Shares 20,986 $0.00 $0.00
Disclosure

SEC source: 0002106809-26-000005 · form4-09282026_040908.xml · nonDerivative · entry 1

Mao Li · CIK 0002106809 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,316

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · shares: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
September 24, 2026 Filed Sep 28, 2026 20:10 UTC GrantOrdinary Shares 20,986 $0.00 $0.00
Disclosure

SEC source: 0001814673-26-000005 · form4-09282026_040909.xml · nonDerivative · entry 1

Heyman Tomas J. · CIK 0001814673 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,720

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · shares: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
September 24, 2026 Filed Sep 28, 2026 20:10 UTC GrantOrdinary Shares 28,330 $0.00 $0.00
Disclosure

SEC source: 0002088468-26-000006 · form4-09282026_040912.xml · nonDerivative · entry 1

Salovey Peter · CIK 0002088468 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,096

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · shares: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
September 21, 2026 Filed Sep 23, 2026 20:15 UTC
Santos Carlos EChief Financial Officer
SaleOrdinary Shares 5,430 $9.14 $49,630.20
Disclosure

SEC source: 0002097065-26-000005 · form4-09232026_040904.xml · nonDerivative · entry 2

Santos Carlos E · CIK 0002097065 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,246

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the vesting of restricted share units.

F3 · price: The price reported in Column 4 is a weighted average price. The prices sold ranged from $8.905 to $9.325 per ordinary share. The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 21, 2026 Filed Sep 23, 2026 20:15 UTC
Santos Carlos EChief Financial Officer
GrantOrdinary Shares 19,676 $0.00 $0.00
Disclosure

SEC source: 0002097065-26-000005 · form4-09232026_040904.xml · nonDerivative · entry 1

Santos Carlos E · CIK 0002097065 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,676

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

Read SEC document
September 15, 2026 Filed Sep 16, 2026 20:18 UTC
Zhang IngridChief Executive Officer
GrantOrdinary Shares 1,131,860 $0.00 $0.00
Disclosure

SEC source: 0001964342-26-000004 · form4-09162026_080948.xml · nonDerivative · entry 1

Zhang Ingrid · CIK 0001964342 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,131,860

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · shares: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs vest and becomes exercisable on each of September 15, 2027, September 15, 2028, and September 15, 2029, respectively, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 20:15 UTC
BASH ALANInterim CEO
GrantOrdinary Shares 4,908 $0.00 $0.00
Disclosure

SEC source: 0001908421-26-000005 · form4-08182026_040805.xml · nonDerivative · entry 1

BASH ALAN · CIK 0001908421 · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,142

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · shares: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs vest and becomes exercisable on each of July 27, 2027, July 27, 2028, and July 27, 2029, respectively, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:05 UTC SaleOrdinary Shares 6,000 $14.80 $88,800.00
Disclosure

SEC source: 0002068365-26-000005 · form4-07022026_040712.xml · nonDerivative · entry 1

Casey Patrick John · CIK 0002068365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,604

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · price: The price reported in Column 4 represents the converted sales price of ADSs of $29.60 per ADS (which is equivalent to $14.80 per ordinary share).

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:05 UTC
Huang YingDirector · Chief Executive Officer
GiftOrdinary Shares 3,382 $0.00 $0.00
Disclosure

SEC source: 0001967360-26-000008 · form4-07022026_040714.xml · nonDerivative · entry 1

Huang Ying · CIK 0001967360 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,490

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · kind: Represents a bone fide gift to a charitable organization.

Read SEC document
June 25, 2026 Filed Jun 30, 2026 01:53 UTC
Huang YingDirector · Chief Executive Officer
SaleOrdinary Shares 5,566 $14.78 $82,265.48
Disclosure

SEC source: 0001967360-26-000006 · form4-06302026_010610.xml · nonDerivative · entry 1

Huang Ying · CIK 0001967360 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 241,872

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · kind: Represents shares sold to satisfy withholding tax obligations upon the vesting of restricted share units.

F3 · price: The price reported in Column 4 is a weighted average price and represents the converted sales price of the ADSs of $29.56. The prices sold ranged from $28.13 to $29.98 per ADS (which is equivalent to $14.065 to $14.99 per ordinary share). The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 25, 2026 Filed Mar 27, 2026 20:25 UTC
Huang YingDirector · Chief Executive Officer
SaleOrdinary Shares 9,936 $8.77 $87,138.72
Disclosure

SEC source: 0001967360-26-000004 · form4-03272026_080347.xml · nonDerivative · entry 1

Huang Ying · CIK 0001967360 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,438

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2 · kind: Represents shares sold to satisfy withholding tax obligations upon the vesting of restricted share units.

F3 · price: The price reported in Column 4 is a weighted average price. The prices sold ranged from $17.26 to $17.82 per ADS (which is equivalent to $8.63 to $8.91 per ordinary share). The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.